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Background: Breast core needle biopsies are not perfect and could miss cancer.
The need for a repeat breast core biopsy is not uncommon and can occur for a
multitude of reasons. Radiologists should carefully correlate the pathology results
with imaging features after each breast biopsy and must recognize why certain core
biopsies must be repeated to avoid missed or delayed cancer diagnosis. In this
review, we discuss the main reasons for repeat core biopsies via case presentation
with radiological images and pathological correlation. This review will help
multidisciplinary breast care team recognize when to repeat a biopsy to reduce false
negatives and will also familiarize radiologists with techniques for improving initial
biopsy success.
Methods: We performed literature and chart reviews of cases at our institution between
January 2015 and December 2019.
Results: While some repeat biopsies are inevitable, most can be avoided with
careful pre-biopsy planning, adequate sampling techniques, and proper radiologicalpathological correlation.
Conclusion: Repeat breast core needle biopsies occur due to multiple avoidable and
unavoidable radiological or pathological issues. It is imperative for both
multidisciplinary breast care team and radiologists to recognize when to repeat a biopsy
to reduce false negative or delayed cancer diagnosis via careful reviews before and after
the procedure and adequate radiological and pathological correlation.
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INTRODUCTION
Core needle biopsy is the standard tool for
diagnosing breast cancer and is often performed by
radiologists under image guidance (mostly ultrasound,
mammogram, or magnetic resonance imaging [MRI]).
Each year approximately 1.6 million breast needle
biopsies are performed in the United States.1 When
compared to open surgical biopsy, a core needle biopsy
has comparable accuracy and lower complication
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rates.2 Unfortunately, core needle biopsies are not
100% accurate and carry the risk of false negatives and
missed cancers.3,4
Radiologists play an important role in evaluating
pathology results after needle biopsies. Given the risk
of false negative results, some benign or atypical
biopsies may require repeating for many reasons. A
meta-analysis of published series has shown 10% of
biopsied lesions required repeat biopsy, with 17% of
these lesions proving malignant.5 Therefore, radiologists must recognize why certain breast biopsies need
repeating so a missed cancer diagnosis may be averted.
Studies also showed that core needle biopsy false
negative rates reduced with experience of the
performing radiologists.6,7 While some repeat biopsies
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are inevitable, most can be avoided with careful prebiopsy planning, proper sampling techniques, and
immediate post biopsy imaging. In addition to
recognizing the necessity of repeat biopsies, radiologists should know how to improve biopsy planning
and techniques that will decrease the need for repeat
biopsies as they cause patient anxiety and increase
medical costs. The goals of this review are to examine
the underlying causes of repeat biopsies through case
presentation with radiological and pathological correlation. This will help the multidisciplinary breast care
team recognize “when and why” to repeat a breast core
biopsy to reduce false negatives and will also
familiarize radiologists with biopsy techniques to
improve initial biopsy success.
METHODS
In our hospital, once a breast biopsy is completed
and pathology results are available, the radiologist
reviews all pertinent imaging and pathology for
correlation. If radiologic-pathologic discordance is
present, a recommendation is made for either a repeat
biopsy or discussion during weekly tumor board.
Based on our review, reasons for repeated biopsies are:
(1) inadequate biopsy technique, (2) challenging or
discordant radiologic-pathologic correlation, (3) issues
with tissue specimen, (4) progression of findings on
post-biopsy follow-up. Using 5 clinical cases selected
from our clinic, we also illustrated how to avoid some
of the repeat biopsy and when to repeat biopsy to avoid
delayed or missed best cancer diagnosis.

RESULTS / DISCUSSION
In our hospital, once a breast biopsy is completed
and pathology results are available, the radiologist
reviews all pertinent imaging and pathology for
correlation. If radiologic-pathologic discordance is
present, a recommendation is made for either a repeat
biopsy or discussion during weekly tumor board.
Based on our review, reasons for repeated biopsies are:
(1) inadequate biopsy technique, (2) challenging or
discordant radiologic-pathologic correlation, (3) issues
with tissue specimen, (4) progression of findings on
post-biopsy follow-up. Using 5 clinical cases selected
from our clinic, we also illustrated how to avoid some
of the repeat biopsy and when to repeat biopsy to
avoid delayed or missed best cancer diagnosis.
Inadequate biopsy technique
Adequate techniques are essential for a successful
breast core biopsy. Studies have shown different false
negative rates for specific core needle biopsies technique. For example, the false negative rate is approximately 2% for ultrasound guided biopsy (6) and 3-4%
for stereotactic biopsy.7,8 The major important technical issues that necessitate repeat biopsies are missing
Wang et al. Arch Breast Cancer 2022; Vol. 9, No. 1: 32-39

the target and choosing an inappropriate image
guidance method.
Poor visualization of lesion and/or needle
Ultrasound-guided biopsy is the most common
breast core biopsy method. It allows real time imaging
of the lesion and needle. Steps toward a successful
ultra-sound-guided biopsy begin with proper lesion
and needle visualization. Awareness of needle angle
relative to the ultrasound probe as it is introduced into
the skin towards the lesion is important. Angles too
steep make visibility difficult, even with larger needles.
Echogenic air introduced through the needle track may
obscure visualization, especially for small and deep
lesions.8 Entry site for deeper lesions is best further
away from the transducer since this gives space to
maneuver the biopsy device horizontally to the chest
wall and the beam of the transducer.5 Obtaining
orthogonal views helps ensure that the needle is
through the lesion. Competent ultrasound-guided
biopsy techniques plus the ability to troubleshoot
during challenging cases will help the radiologist avoid
missing a target.
Dense breast tissue and fibrosis
Dense or fibrotic tissue is difficult to for the biopsy
needle to traverse through the tissue, especially during
ultrasound-guided biopsy. In the dense tissue, the core
needle can be very difficult to advance via single hand.
In this case, a sharp or large gauge needle with
introducer may be used and a biopsy track can be
generated through needle firing before sampling.
Coaxial method may be beneficial to confirm adequate
targeting and sampling in ultrasound guided biopsy.
Once a coaxial needle is in place, access to the lesion
is achieved. Rotation and manipulation of the
transducer and needle may be necessary to ensure
sampling through different parts of the lesion.5
Choosing the wrong biopsy method
Although exceptions do exist, the imaging modality
of choice for a biopsy should be the one that will show
the suspicious finding with the most confidence.
Typically, ultra-sound-guided biopsies are utilized for
masses; stereotactic-guided biopsies for calcifications,
architectural distortion, and asymmetries; and MRIguided biopsies for suspicious MRI findings. However,
in clinical practice, ultrasound-guided biopsy is often
preferred by patients and radiologists for a few reasons:
low cost, portability, minimal equipment requirement,
no radiation, real time imaging, being less invasive,
and the possibility of a more comfortable biopsy
position for the patients. Second-look ultrasound is
commonly performed for mammographic or MRI
findings.9 Before utilizing ultrasound-guided biopsies
for these abnormalities, all images must be reviewed to
ensure correct targeting.10 After the biopsy, a biopsy
clip should be placed in the biopsy site and post biopsy
33
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mammogram should be performed to confirm appropriate targeting.
Figure 1 illustrates how utilizing an inappropriate
imaging modality for a core biopsy can result in
missing the intended target and subsequently delaying
diagnosis. In this case, the ultrasound correlate for the
mammographically detected architectural distortion
was incorrect, thus resulting in a wrong biopsy site
when ultrasound-guided biopsy was attempted. Repeat
stereotactic biopsy was recommended to target the
architectural distortion. Mammograms after the repeat
biopsy confirmed the right targeting of this lesion,

which was proven to be malignant. Necessity of a post
procedure mammogram and placement of a biopsy clip
is also nicely depicted in Figure 1. Post clip images
allowed the radiologist to see if the intended mammographic finding was appropriately targeted. Final
pathology for the initial biopsy was benign which was
concordant for the ultrasound finding, but not for the
intended target on mammogram. Repeat biopsy was
performed after careful review of the images and the
missed cancer was caught on repeat biopsy without
much delay.

Figure 1. Missed target resulting from wrong biopsy imaging selection. A 44-year-old female with screening callback. a. Right
craniocaudal and b. mediolateral oblique. views show an area of architectural distortion in the 12:00 of the right breast (white
circle). c, d. Ultrasound images. at 12:00, 5cm from the nipple show an avascular irregular mass (black arrows) with angular
margins. e. This likely correlates to mammographic finding post clip mammogram from initial ultrasound–guided biopsy shows
U clip (white arrow) in unexpected location, anterior to architectural distortion (dashed white circle). Initial biopsy: discordant
benign pathology—non-proliferative fibrocystic changes. Repeat stereotactic biopsy recommended. f. Post clip mammogram
from repeat stereotactic biopsy shows the M clip in appropriate location (white circle). Repeat biopsy: Concordant malignant
pathology—Grade 1 Invasive ductal carcinoma with ductal carcinoma in situ.

Challenging or discordant radiologic-pathologic
correlation
Both radiological and pathological factors can be
associated with repeat breast core biopsy. In a study
conducted by Boba et al., radiological failure resulted
in 0.8% of biopsy false negative rates and histopathology constituted 1.5% of diagnosed cancers and
atypia.10 Despite optimal biopsy technique, failure to
sample cancer may happen, possibly due to histologic
heterogeneity within the lesion. Breast cancer can
contain areas of normal breast tissue and fibrosis.
Atypical or precancerous lesions can also coexist with
the breast cancer during cancer development.11 Figure
2 demonstrates the consequences of under sampling,
likely due to histologic heterogeneity with presence
of normal breast tissue or benign breast lesions.
34

Furthermore, histopathological interpretation is a
significant cause for false-negative results, especially
equivocal pathology.10 Studies show that pathologists
are particularly good at diagnosis of invasive cancer
in a biopsy specimen but are less accurate at making
the correct diagnosis with high risk or benign
tissue.1,10 According to one study,1 pathologists’
under-interpretation rates for ductal carcinoma in situ
(DCIS) and atypia are 17% and 35%, respectively.
Final pathology for the initial biopsy in Figure 3 was
interpreted as a papilloma. However, the radiologist
recommended surgical consultation due to concerning
imaging features. Pathology from the surgical
excision revealed low-grade DCIS in addition to IDP.
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Figure 2. a–f. Radiology-pathology discordance (probably under-sampling) with timely management. A 46-year-old female
presented for screening. a. Part of the left craniocaudal view shows architectural distortion at 2:00, 12cm from the nipple
(white circle). b. Focused ultrasound image at 2:00, 12cm from the nipple, shows a 15mm irregular mass with spiculated
margins (blue arrow), likely correlating with mammographic finding. c. Image from ultrasound-guided biopsy demonstrates
sampling through the hypoechoic mass. d. Craniocaudal view from post-procedure mammogram shows U clip (blue arrow),
close to area of architectural distortion (white circle). Initial biopsy: discordant benign pathology—benign breast tissue/
pseudoangiomatous stromal hyperplasia. e. Repeat stereotactic biopsy 5 days later. f. Post-biopsy mammogram craniocaudal
view with ribbon clip (white arrow), which migrated laterally from biopsy site (white circle). Repeat biopsy: concordant
malignant pathology—invasive well-differentiated lobular carcinoma.

Figure 3. a–f. Challenging pathology (equivocal lesion) upgraded with surgical excision. A 68-year-old female screening
callback. a. Craniocaudal implant displaced view shows a 3mm mass in the lateral left breast (white circle) 5cm from the
nipple. The U clip shown is from prior benign biopsy. b. Ultrasound image shows an irregular mass with indistinct margins
that may correlate with the mammographic finding. c. Image from ultrasound-guided biopsy shows proper targeting. d. Postbiopsy mammogram craniocaudal view shows eye clip in appropriate location (white circle). Initial biopsy: concordant benign
pathology—papilloma with atypical ductal hyperplasia. Surgical excision recommended. e. Craniocaudal view following wire
localization for surgical excision and f. post-lumpectomy surgical specimen radiography show adequate excisional biopsy.
Repeat biopsy: concordant malignant pathology—ductal carcinoma in situ and intraductal papilloma (IDP).
Wang et al. Arch Breast Cancer 2022; Vol. 9, No. 1: 32-39
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It is essential for the radiologist to carefully
correlate pathology results of the biopsy with image
features of the target. When discordant benign or
atypical pathology intersects suspicious imaging
features, the radiologist must analyze imaging
features and discuss findings with the pathologist. To
adequately correlate histology with radiologic
findings, radiologists must be familiar with the gamut
of pathologic and benign imaging features.5 Careful
radiology-pathology correlation can help avoid the
false negative result via timely repeat biopsy. At our
institution, discordant radiologic-pathologic diagnoses are either re-biopsied or discussed at weekly
multidisciplinary tumor boards for further management. All high-risk lesions (atypia, lobular carcinoma in situ, radial scar/complex sclerosing lesion,
papillary lesions, fibroepithelial lesions) are also
discussed at the tumor boards. Management often
includes repeat biopsy, surgical excision, or 6-month
image follow-up.
Issues with tissue specimen
Obtaining specimen radiographs is important for
confirming retrieval of calcifications during
stereotactic or ultrasound-guided biopsies. If
calcifications are not present, timely and appropriate
trouble shooting should be performed. Depending on
the underlying causes, additional samples,
retargeting, or switching biopsy methods should be
considered if calcifications are not present on
specimen radiographs due to inadequate tissue

sampling. However, 6% specimens that did not show
calcifications in radiology were described as calcified
in final biopsy results by pathologists.12 Calcifications
that are not detected in the specimen radiograph can
be aspirated into the debris stuck in biopsy equipment
tubing and collecting basket or canister during the
stereotactic vacuum-assisted biopsy.13 One type of
calcification – oxalate crystals – while often seen in
the specimen radiography, are not detected by the
routine pathology section and requires more
comprehensive histologic examination, such as
polarizing lenses.
Although the sampling of calcifications is mostly
conducted with stereotactic guidance, ultrasound
guidance can be performed in special situations where
the stereotactic biopsy is not feasible. Biopsy of
calcifications under ultrasound-guidance can be
tricky, but certain techniques (i.e., open-trough
method) may help minimize failure. Figure 4 demonstrates the importance of a specimen radio-graph.
Upon completion of the initial ultrasound-guided
biopsy, a specimen radiograph was not performed,
and the clip was just anterior to the calcifications on
the post-procedure mammogram. A repeat ultrasound-guided biopsy was performed followed by a
specimen radiograph confirming retrieval of calcifications. Final pathology was malignant. If calcifications cannot be confidently sampled with ultrasound-guidance, a stereotactic-guided biopsy, when
possible, should be utilized.

Figure 4. a–g. Importance of specimen radiograph. A 49-year-old female presented with a palpable concern. a. Right
mediolateral oblique view shows focal asymmetry with fine linear-branching calcifications (white circle). b. Ultrasound image
shows a mass with possible calcifications (orange arrow). c. Ultrasound-guided biopsy image shows sampling through
hypoechoic mass. d. Post clip mammogram with U clip (orange arrow) anterior to the calcifications. No specimen radiograph
was obtained. Initial biopsy: discordant benign pathology—stromal fibrosis and fibrocystic changes without calcifications.
Repeat biopsy was performed. e. Repeat ultrasound-guided biopsy sampling through hypoechoic mass and calcifications
(white arrow). f. Post clip mammogram shows eye clip (white arrow) in appropriate location within the calcifications. g.
Specimen radiograph obtained after 5 core specimens show calcifications in all 5 specimens. Repeat biopsy: concordant
malignant pathology—high grade ductal carcinoma in situ.
36
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Progression and localization of MRI findings on
post-biopsy follow-up
To avoid the delayed cancer diagnosis from false
negatives of the core needle breast biopsies, some
radiologists have found post-biopsy follow-up to be
helpful, even for concordant benign diagnoses. False
negative biopsy rate is often higher in the MRI guided
biopsy than in the ultrasound guided biopsy due to
uncertain lesion localization and lack of real time
image guidance. Second look ultrasound is typically
used to find a sonographic correlate for suspicious
MRI findings to allow for an ultrasound-guided core
needle biopsy.14,15 However, it does not come without
challenges. It is important to know how various
lesions may present on both MRI and US and to also
use the largest number of anatomical landmarks or
other findings such as cysts when correlating between
the two modalities. Furthermore, it is important to
take into consideration the differences in positioning
between MRI and US as in US, the patient is either in
a supine or supine oblique position and for MRI the
patient is prone. A US correlate is more likely to be
found for larger masses or if it is an invasive cancer
as opposed to smaller lesions or non-mass enhancement.15 Clip confirmation is also important following a US-guided biopsy as clips can be displaced or

end up in a completely wrong position because a
wrong lesion has been targeted. Standard practice is
to obtain a post biopsy mammogram to confirm clip
placement. A T1-wieghted gradient echo sequence
could also be obtained to confirm the biopsy clip
location. If the MRI lesion of interest is a large area
of enhancement but the sonographic correlate is much
smaller, that needs to be taken into consideration if
needle localization will be performed for
lumpectomy.
It will be important to localize the clip in
relationship to the entire extent of disease involveement. Recent studies,16,17 have showed that there is
up to 4% false negative rate for benign MRI biopsy
with concordant radiology-pathology correlation.
Thus, patients with benign biopsy may be recommended for imaging follow-up to confirm the stability
of biopsied imaging findings. Patient compliance with
follow-up is essential to minimize further delay,5
especially in patients who are at high risk for developing breast cancer and require close monitoring for
the biopsy proven benign lesions. Figure 5 shows the
importance of close, short-term surveillance following a benign MRI biopsy in a high-risk patient. In
this case, a cancer was missed on the initial biopsy
and the cancer had progressed significantly when the
patient missed the follow-up.

Figure 5. a–e. Delayed cancer diagnosis due to failure in follow-up of a false negative MRI biopsy. A 35-year-old female
with positive breast cancer gene (BRCA1). a. Screening MRI axial post contrast subtraction imaging shows a 9mm irregular
mass with delayed washout curve at 12:00 of right breast, 3cm from the nipple. b. MRI biopsy was performed. Initial biopsy:
concordant benign pathology—non-proliferative fibrocystic changes with dense fibrosis. Follow-up MRI 14 months later
(patient had difficulty scheduling MRI due to insurance issues). c, d. Axial post contrast subtraction and maximum intensity
projection images show large volume diffuse non-mass enhancement measuring 69mm, occupying the entire right breast. e.
Ultrasound biopsy was performed. Repeat biopsy: concordant malignant pathology—Infiltrating poorly differentiated grade
3 ductal carcinoma.
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CONCLUSION
Repeat breast core needle biopsies occur due to
multiple radiological or pathological issues. While
some repeat biopsies are inevitable, most can be
avoided by careful pre-procedure planning, improvement of biopsy techniques, post procedure imaging,
and adequate radiology-pathology correlation. It is
imperative for multidisciplinary breast care team to
recognize reasons for the need for a repeat breast
biopsy to avoid false negative or delayed diagnosis of
breast cancer. The performing radiologist’s experience and knowledge are very important in increasing
initial biopsy success rate by providing appropriate
planning and optimized biopsy techniques. With
multidisciplinary approach and careful review of the
repeated breast core needle biopsy, we can not only
improve to the chances of having an accurate

diagnosis in a timely fashion, but also help reduce
patient’s anxiety and the unnecessary cost of a
potentially avoidable additional biopsy or medical
procedure.
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